Search research articles
Contact Us
Filters
Showing results (71-80 of 72) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 72 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2009
Yttrium-90 ibritumomab tiuxetan doses calculated to deliver up to 15 Gy to critical organs may be safely combined with high-dose BEAM and autologous transplantation in relapsed or refractory B-cell non-Hodgkin's lymphoma
Jane N Winter, David J Inwards, Stewart Spies, et al.
Hepatology Communications
|
February 7, 2018
CAT-2003: A novel sterol regulatory element-binding protein inhibitor that reduces steatohepatitis, plasma lipids, and atherosclerosis in apolipoprotein E*3-Leiden mice
Michael Zimmer, Pradeep Bista, Ericka L Benson, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 72) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 72 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2009
Yttrium-90 ibritumomab tiuxetan doses calculated to deliver up to 15 Gy to critical organs may be safely combined with high-dose BEAM and autologous transplantation in relapsed or refractory B-cell non-Hodgkin's lymphoma
Jane N Winter, David J Inwards, Stewart Spies, et al.
Hepatology Communications
|
February 7, 2018
CAT-2003: A novel sterol regulatory element-binding protein inhibitor that reduces steatohepatitis, plasma lipids, and atherosclerosis in apolipoprotein E*3-Leiden mice
Michael Zimmer, Pradeep Bista, Ericka L Benson, et al.
Page
of 8